Amedeo Smart

Free Medical Literature Service


 

Amedeo

Malignant Melanoma

  Free Subscription

18.05.2026

2 Am J Ophthalmol
1 Ann Surg Oncol
2 Br J Dermatol
2 J Invest Dermatol
4 Melanoma Res
1 Proc Natl Acad Sci U S A



    Am J Ophthalmol

  1. DAVE N, Taylor Gonzalez DJ, Cernichiaro-Espinosa LA, King BA, et al
    One-Year Tumor Volume Regression Predicts Survival After I-125 Plaque Brachytherapy for Posterior Uveal Melanoma.
    Am J Ophthalmol. 2026 May 12:S0002-9394(26)00239.
    >> Share

  2. VAISMAN D, Pe'er J, Eiger-Moscovich M, Lotem M, et al
    Reply to comments on Interferon Alpha-2a as Treatment for Primary Acquired Melanosis with Atypia (PAMwA) and for PAMwA surrounding conjunctival melanoma.
    Am J Ophthalmol. 2026 May 9:S0002-9394(26)00226.
    >> Share


    Ann Surg Oncol

  3. BARTLETT EK, Panageas KS, Coit DG
    Perspective Editorial: Assessment of Survival Benefit from Sentinel Node Biopsy for Melanoma: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2026 May 8. doi: 10.1245/s10434-026-19776.
    >> Share


    Br J Dermatol

  4. MCGRATH JA, Olsen CM
    Mole counts, melanoma, and the dermatologist's next "vital sign".
    Br J Dermatol. 2026 May 9:ljag178. doi: 10.1093.
    >> Share

  5. KARPONIS D, Nikolaou V, Stratigos AJ, Mistry K, et al
    Epidemiology of lentigo maligna and lentigo maligna melanoma in England between 2013-2023.
    Br J Dermatol. 2026 May 8:ljag177. doi: 10.1093.
    >> Share


    J Invest Dermatol

  6. SAHU A, Gill M, Hermawan A, Shinde A, et al
    PARP1 as a biomarker for differentiating melanoma from benign melanocytic lesions.
    J Invest Dermatol. 2026 May 12:S0022-202X(26)01198.
    >> Share

  7. JAYASINGHE D, Torrano J, Betz-Stablein B, Janda M, et al
    Nevus clustering on the back associated with in situ melanoma in a Queensland melanoma high-risk cohort.
    J Invest Dermatol. 2026 May 6:S0022-202X(26)01186.
    >> Share


    Melanoma Res

  8. AZIZ H, Pirzada H, Ahmad A, Iqbal J, et al
    Re-evaluating melanoma treatment: a comparative look at herpes simplex virus and coxsackievirus oncolytic therapies in advanced melanoma: a meta-analysis of clinical trials.
    Melanoma Res. 2026 May 14. doi: 10.1097/CMR.0000000000001105.
    >> Share

  9. VAN DOREN AGS, Shah H, Chen R, Shah D, et al
    Variability in synoptic reporting and inclusion of essential histopathologic elements in cutaneous melanoma biopsy pathology reports.
    Melanoma Res. 2026 May 14. doi: 10.1097/CMR.0000000000001106.
    >> Share

  10. ZHANG Y, Borna S, Saw-Martinez R
    Sentinel lymph node detection in melanoma: indocyanine green fluorescence compared with conventional mapping techniques.
    Melanoma Res. 2026 May 11. doi: 10.1097/CMR.0000000000001104.
    >> Share

  11. DALVIN LA, Burr SD, Miley DR, Ong H, et al
    Novel uveal melanoma patient-derived cell line and organoid models show increased treatment resistance compared with commercially available cell lines.
    Melanoma Res. 2026 May 11. doi: 10.1097/CMR.0000000000001103.
    >> Share


    Proc Natl Acad Sci U S A

  12. YANG X, Qiao X, Schmidt S, Eklund EA, et al
    ICMT supports BRAF(V600E)-driven tumor growth by membrane targeting of the CAAX protein INPP5E.
    Proc Natl Acad Sci U S A. 2026;123:e2601795123.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016